Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab has shown antifibrotic efficacy in a mouse model of idiopathic pulmonary fibrosis and can be used in studies of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF).
- Size: 1mg
- Purity: ≥95%
- Physical State: Colorless to light yellow Liquid
- Brand: Saint Michael
- Catalogue No.: IA8860-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review